Robert Schreiber, PhD, FAACR, Andrew M. and Jane M. Bursky Distinguished Professor of Pathology & Immunology at Washington University School of Medicine, has received the American Association for Cancer Research’s (AACR) Princess Takamatsu Memorial Lectureship. The award “recognizes an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of Princess Takamatsu to multinational collaborations,” AACR said in a statement.
Dr. Schreiber, who is also Director of the Bursky Center for Human Immunology and Immunotherapy Programs at Washington University School of Medicine, was recognized by AACR for his impactful research that led to an improved understanding of immune surveillance in cancer pathogenesis, including the definition of the physiologic roles and mechanisms of action of Type I interferon and Interferon gamma in cancer-associated immune responses, and for establishing the concept of “immunoediting” that has since fueled the development of cancer immunotherapeutics. Dr. Schreiber delivered his award lecture on April 17, 2023, at the AACR Annual Meeting in Orlando, Florida.
